Cochrane Abstracts
First‐line allogeneic hematopoietic stem cell transplantation of HLA‐matched sibling donors compared with first‐line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"First‐line Allogeneic Hematopoietic Stem Cell Transplantation of HLA‐matched Sibling Donors Compared With First‐line Ciclosporin And/or Antithymocyte or Antilymphocyte Globulin for Acquired Severe Aplastic Anemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437122/all/First‐line_allogeneic_hematopoietic_stem_cell_transplantation_of_HLA‐matched_sibling_donors_compared_with_first‐line_ciclosporin_and_or_antithymocyte_or_antilymphocyte_globulin_for_acquired_severe_aplastic_anemia.
First‐line allogeneic hematopoietic stem cell transplantation of HLA‐matched sibling donors compared with first‐line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437122/all/First‐line_allogeneic_hematopoietic_stem_cell_transplantation_of_HLA‐matched_sibling_donors_compared_with_first‐line_ciclosporin_and_or_antithymocyte_or_antilymphocyte_globulin_for_acquired_severe_aplastic_anemia. Accessed January 18, 2025.
First‐line allogeneic hematopoietic stem cell transplantation of HLA‐matched sibling donors compared with first‐line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437122/all/First‐line_allogeneic_hematopoietic_stem_cell_transplantation_of_HLA‐matched_sibling_donors_compared_with_first‐line_ciclosporin_and_or_antithymocyte_or_antilymphocyte_globulin_for_acquired_severe_aplastic_anemia
First‐line Allogeneic Hematopoietic Stem Cell Transplantation of HLA‐matched Sibling Donors Compared With First‐line Ciclosporin And/or Antithymocyte or Antilymphocyte Globulin for Acquired Severe Aplastic Anemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437122/all/First‐line_allogeneic_hematopoietic_stem_cell_transplantation_of_HLA‐matched_sibling_donors_compared_with_first‐line_ciclosporin_and_or_antithymocyte_or_antilymphocyte_globulin_for_acquired_severe_aplastic_anemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - First‐line allogeneic hematopoietic stem cell transplantation of HLA‐matched sibling donors compared with first‐line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia
ID - 437122
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437122/all/First‐line_allogeneic_hematopoietic_stem_cell_transplantation_of_HLA‐matched_sibling_donors_compared_with_first‐line_ciclosporin_and_or_antithymocyte_or_antilymphocyte_globulin_for_acquired_severe_aplastic_anemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
